Abstract
ABSTRACTProduct quality heterogeneities, such as a trisulfide bond (TSB) formation, can be influenced by multiple interacting process parameters. Identifying their root cause is a major challenge in biopharmaceutical production. To address this issue, this paper describes the novel application of advanced multivariate data analysis (MVDA) techniques to identify the process parameters influencing TSB formation in a novel recombinant antibody–peptide fusion expressed in mammalian cell culture. The screening dataset was generated with a high‐throughput (HT) micro‐bioreactor system (AmbrTM 15) using a design of experiments (DoE) approach. The complex dataset was firstly analyzed through the development of a multiple linear regression model focusing solely on the DoE inputs and identified the temperature, pH and initial nutrient feed day as important process parameters influencing this quality attribute. To further scrutinize the dataset, a partial least squares model was subsequently built incorporating both on‐line and off‐line process parameters and enabled accurate predictions of the TSB concentration at harvest. Process parameters identified by the models to promote and suppress TSB formation were implemented on five 7 L bioreactors and the resultant TSB concentrations were comparable to the model predictions. This study demonstrates the ability of MVDA to enable predictions of the key performance drivers influencing TSB formation that are valid also upon scale‐up. Biotechnol. Bioeng. 2017;114: 2222–2234. © 2017 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
Highlights
Biopharmaceutical manufacturing utilizing mammalian cell culture expression systems has seen unprecedented growth in the last two decades
Two multivariate data analysis (MVDA) techniques were implemented to leverage significant insights from the design of experiments (DoE) datasets generated with the AmbrTM-15 system
The first MVDA technique applied was an Multiple linear regression (MLR) model that identified the key process conditions resulting in high trisulfide bond (TSB) concentrations
Summary
Biopharmaceutical manufacturing utilizing mammalian cell culture expression systems has seen unprecedented growth in the last two decades This growth has been facilitated by the generation of robust and high-yielding cell lines, application of scale-down mimics and high-throughput technologies, increased process understanding and development of standardized platforms. These advancements have enabled a reduction on the emphasis of maximizing titre and shifted focus onto reducing product development timelines (Bareither and Pollard, 2011; Shukla and Th€ommes, 2010) while ensuring consistent product quality profiles (Lubiniecki et al, 2011; Pacis et al, 2011; Zhou and Kantardjieff, 2013). This paper investigates the potential of multivariate data analysis (MVDA) to fully exploit cell culture data and evaluate the key parameter interactions adversely impacting cell culture product heterogeneity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.